Found 4366 articles for: ""
Neurogenic Rosacea Treatment: A Literature Review
June 2023 | Volume 22 | Issue 6 | Original Article | 566 | Copyright © June 2023
Rosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morpholo...
Read MoreDiacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial
June 2023 | Volume 22 | Issue 6 | Original Article | 599 | Copyright © June 2023
Background: In epidermolysis bullosa simplex (EBS), epithelial structural fragility results in blisters and erosions. Diacerein 1% ointment has been shown to reduce this blisteri...
Read MoreGender-Affirming Hormone Therapy Among Transgender and Gender Diverse Patients Receiving Laser Hair Removal Prior to Gender-Affirming Surgery
June 2023 | Volume 22 | Issue 6 | Editorials | 619 | Copyright © June 2023
Biologic Vs Conventional Therapies: Comparing Risk of Psoriasis-Associated Comorbidities
June 2023 | Volume 22 | Issue 6 | Original Article | 621 | Copyright © June 2023
Psoriasis is associated with multiple comorbidities. In this retrospective cohort analysis, we compared the comorbidities in patients who received biologic treatments with those who received conventio...
Read MoreRole of Retinoic Acid Receptor Subtypes in the Pathophysiology of Acne
June 2023 | Volume 22 | Issue 6 | Original Article | 608 | Copyright © June 2023
Cross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular Diseases
June 2023 | Volume 22 | Issue 6 | Original Article | 576 | Copyright © June 2023
Background: A growing body of evidence suggests that several inflammatory skin diseases (ISDs) are associated with systemic inflammation and cardiovascular disease (CVDs)....
Read MoreCeramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment
June 2023 | Volume 22 | Issue 6 | Original Article | 554 | Copyright © June 2023
Barrier damage caused by facial acne vulgaris can be magnified by topical medication, such as adapalene (0.3%) and benzoyl peroxide (2.5%)(A/BPO), which utilizes a retinoid to normalize follicula...
Read MoreTopical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas
June 2023 | Volume 22 | Issue 6 | Original Article | 594 | Copyright © June 2023
Background: Oral propranolol is considered the first line therapy in the treatment of infantile hemangiomas (IHs). However, there are considerable side effects due to its ability to p...
Read MorePlacement of High Dose Neurotoxins for Treatment-Resistant Rosacea
June 2023 | Volume 22 | Issue 6 | Case Reports | 605 | Copyright © June 2023
Rosacea is a chronic inflammatory skin condition characterized by facial flushing, erythema, telangiectasias, and papulopustular lesions. Treatment for rosacea includes limiting inciting factors ...
Read MoreIncreased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa
June 2023 | Volume 22 | Issue 6 | Features | 615 | Copyright © June 2023
Background: TNF-inhibitor adalimumab 40 mg/week (ADA40) is the only approved treatment for hidradenitis suppurativa (HS); however, it is not uniformly effective. Despite a high p...
Read MoreUnmet Needs in the Management of Acne Vulgaris: A Consensus Statement
June 2023 | Volume 22 | Issue 6 | Original Article | 582 | Copyright © June 2023
Acne vulgaris is the most common skin condition in the US, affecting up to 50 million Americans. The American Academy of Dermatology (AAD) guidelines on acne treatment were developed to provide r...
Read MoreSupplement Individual Article: Chelating Agents in Skincare: Comprehensive Protection Against Environmental Aggressors
May 2023 | Volume 22 | Issue 5 | Supplement Individual Articles | SF383499s5 | Copyright © May 2023
In addition to ultraviolet light, skin is regularly exposed to several environmental stressors that can cause damage and premature aging. Particulate matter in the environment, including transiti...
Read MoreFULL SUPPLEMENT: Environmental Aggressors And Comprehensive Protection: Chelating Agents In Skincare
May 2023 | Volume 22 | Issue 5 | Department | SF383499s4 | Copyright © May 2023
ENVIRONMENTAL AGGRESSORS AND COMPREHENSIVE PROTECTION: CHELATING AGENTS IN SKINCARE(BASED ON A MEDSCAPE EDUCATION ONLINE ACTIVITY)...
Read MoreA Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input
May 2023 | Volume 22 | Issue 5 | Original Article | 496 | Copyright © May 2023
Dermatologic surgeons are encountering more patients on antithrombotic agents. There are no established consensus guidelines for managing antithrombotic agents in the perioperative period. We pro...
Read MoreKeratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin
May 2023 | Volume 22 | Issue 5 | Original Article | 486 | Copyright © May 2023
Background: The incidence of keratinocyte carcinomas (KCs), comprising basal and squamous cell carcinomas, is rising in the United States. Chemoprevention is one modality by whic...
Read MoreNon-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage
May 2023 | Volume 22 | Issue 5 | Original Article | 481 | Copyright © May 2023
Background: To investigate the effectiveness, safety, patient satisfaction, and cosmetic outcome of Methyl Aminolevulinate-Photodynamic Therapy (MAL-PDT) following curettage in o...
Read MoreDiversifying the Mohs Workforce: Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship
May 2023 | Volume 22 | Issue 5 | Original Article | 471 | Copyright © May 2023
Background: The population of the United States is becoming increasingly diverse, yet dermatology, especially Mohs micrographic surgery (MMS), lags behind.Ob...
Read MoreUltraviolet B-Rays Induced Gene Alterations and DNA Repair Enzymes in Skin Tissue
May 2023 | Volume 22 | Issue 5 | Original Article | 465 | Copyright © May 2023
Background: Ultraviolet (UV) radiation leads to deoxyribonucleic acid (DNA) damage and changes in gene expression. Topical DNA repair enzymes in liposomes are capable of undoing ...
Read MoreAssessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ
May 2023 | Volume 22 | Issue 5 | Original Article | 457 | Copyright © May 2023
Background: The standard of care when treating melanoma in situ (MMIS) is an excision with at least 5 mm surgical margins.1 Some studies have suggested up to 9 mm margins to maxi...
Read MoreAllergens in Common Brands of Clobetasol
May 2023 | Volume 22 | Issue 5 | Original Article | 491 | Copyright © May 2023
Media and other results for: ""